Seminars

Matthew J. Girgenti discusses how research on individual brain cells and the three-dimensional organization of DNA is changing the biological understanding of post-traumatic stress disorder. The seminar examines how these approaches reveal trauma-associated brain changes and identify possible targets for more effective, personalized treatments. Girgenti is a neuroscientist in Yale School of Medicine’s Department of Psychiatry. Jeffrey Borenstein moderates this Meet the Scientist session. Online via the BBRF Zoom webinar. Tuesday 13 October 2026, 14:00 EDT (America/New_York; UTC−4). Follow Register Today on the organizer’s event page to the event-specific Zoom form. Advance registration is available to researchers, students, healthcare providers, mental-health organizations, patients and family members.

Ilaria Ferlenghi discusses a career spanning structural biology, cryo-electron microscopy, vaccine research and development, and the growing role of artificial intelligence and machine learning in scientific innovation and entrepreneurship.

Tim Ebbels presents interpretable machine-learning models for metabolomics and multi-omics using pathway and chemical-class scores. Sparse coverage of the metabolome and uncertain annotations make conventional results difficult to interpret; pathway-based features aim to connect model output directly to biological function. The webinar examines applications from multi-assay mass spectrometry and multi-omics integration to single-cell and mass-spectrometry imaging, discusses methodological challenges and attempts to resolve them, and demonstrates how these approaches can clarify complex biological signals. Online via Zoom. Free for interested life scientists and bioinformaticians, with advance registration required through the Australian BioCommons event page. Tuesday 13 October, 16:00–17:00 AEDT (Australia/Melbourne), equivalent to 05:00–06:00 UTC. The event is subject to the BioCommons Code of Conduct and may be recorded.

Yun Xia presents macrophage–kidney assembloids that address missing immune and vascular components in stem-cell organoids. Directed differentiation, self-organization, genetic perturbation, xenotransplantation and single-cell analysis reveal immune–epithelial interactions. Macrophages from the same parental cells acquire resident phenotypes; diabetic and polycystic kidney models show context-dependent effects on inflammation, epithelial injury and disease progression. Minoru Takasato addresses kidney organoids’ missing urinary outflow by generating bladder tissue from human pluripotent cells. Stepwise differentiation passes through endoderm, hindgut and cloaca; FGF4 posteriorization and growth-factor screening promote urothelial identity. The resulting sacs contain stratified urothelial cell types, stretch and form a barrier, supporting developmental, disease and future therapeutic studies. Online via Zoom. Tuesday 13 October, 11:00–12:30 SGT (Asia/Singapore). Both talks share this session; individual start times are unspecified. Register through the organizer page. Professional, trainee or student status in stem cells, regenerative medicine or an adjacent field is required; organizer approval and recording restrictions apply.

Tom Nowakowski explains lineage barcoding and single-cell sequencing approaches for reconstructing neural stem-cell family trees and early wiring programs in developing mouse and human brains.

Anthony Letai discusses how understanding programmed cell death can guide the selection of cancer treatments. The seminar explains how apoptotic signalling can be measured and how these measurements can identify drugs capable of killing cancer cells. Hybrid: New Research Building Auditorium, Georgetown University Medical Center, Washington, DC, and Zoom. Monday 5 October 2026, 16:30–17:30 EDT (America/New_York; UTC−4). Use the attendance registration form or the event’s Zoom link on the organizer page. Organized by Georgetown’s Distinguished Scientist Seminar Series. Letai is Director of the National Cancer Institute. An in-person reception follows the seminar.

Farhad Danesh examines how mitochondrial reactive oxygen species, altered metabolism and structural remodelling convert hyperglycaemia into progressive kidney injury. The seminar connects mitochondrial dynamics with diabetic microvascular damage, non-coding RNA regulation and experimental models that establish causal links to disease progression. Genome-wide CRISPR screens and spatial metabolomics reveal cellular gene-regulatory and metabolic changes. Integrating these approaches with molecular genetics, genomics and epigenomics, the work seeks therapeutic targets to prevent diabetic kidney disease progressing to kidney failure. Hybrid: New Research Building Auditorium, Georgetown University Medical Center, Washington, DC, and Zoom. Thursday 24 September 2026, 16:00–17:00 EDT (America/New_York; UTC−4). Use the public event registration form to arrange attendance, or follow its Zoom link for remote participation. Organized by Georgetown’s Distinguished Scientist Seminar Series. Danesh is Professor of Medicine and Chief of Nephrology at MD Anderson.

Mariana Wolfner presents research on the molecular changes in eggs, sperm, and females that coordinate successful reproduction, drawing on genetic and physiological studies of fertilization. This NIH Wednesday Afternoon Lecture Series event is offered in person and through NIH VideoCast.

MIT Biology Colloquium Series talk by David Bilder (University of California, Berkeley), hosted by Yukiko Yamashita, on invertebrate oncology and the ancient evolutionary origins of tumor-host interactions.

Shiv Grewal discusses how chromatin and epigenetic mechanisms establish, maintain, and transmit genome states beyond the DNA sequence itself. This NIH Wednesday Afternoon Lecture Series event is offered in person and through NIH VideoCast.

This English-language webinar examines advances in organoid research, production, and drug discovery. Hideya Sakaguchi covers the developmental-biology origins of neural organoid research and its potential for drug discovery, followed by a keynote from Thomas Mitchell of The Organoid Company and a live question session.

Suhrid Ghosh will present work on how cell mechanics and cytoskeletal dynamics shape the evolution of reproductive structures in Drosophila ovaries. Cross-species morphology, ex-vivo live imaging, perturbations of cortical tension, and newly isolated terminal-filament cells reveal how somatic-cell deformability can alter ovariole architecture and reproductive fitness.

UC Berkeley Molecular & Cell Biology seminar (Divisions of Biochemistry, Biophysics & Structural Biology; Cell Biology, Development & Physiology; and Genetics, Genomics, Evolution & Development) by Luke Gilbert of UCSF on repurposing CRISPR systems to activate and silence genes.

UC Berkeley Molecular & Cell Biology seminar (Division of Genetics, Genomics & Development) by Barak Cohen of Washington University in Saint Louis on massively parallel experimental studies of enhancer function.

Thesis presentation by Tiffany Zhang, graduate fellow in the Vinogradova Lab at The Rockefeller University, on chemical proteomics approaches revealing post-translational remodeling of endosomal pathways during macrophage activation. Open to the tri-institutional community.

Klemens Rottner (Helmholtz Centre for Infection Research, Braunschweig) presents evidence that profilin acts as a master regulator of actin filament dynamics essential for cell migration and growth, controlling both formin- and Arp2/3 complex-dependent actin assembly pathways.

Shimon Sakaguchi, Mary E. Brunkow and Fred Ramsdell explain how peripheral immune tolerance prevents the immune system from attacking the body. Sakaguchi follows the identification of regulatory T cells, the CD25 marker, and the relationship between central tolerance and active suppression of self-reactive cells. He considers how changing regulatory T-cell activity could support cancer treatment and transplantation. Brunkow describes genetic investigation of scurfy mice, identification of FOXP3, and the connection between mutations in this gene and human IPEX syndrome. The work establishes a molecular basis for the development and function of regulatory T cells. Ramsdell traces the move from these basic discoveries toward therapeutic strategies, including engineering a patient’s regulatory T cells to target inflammation in rheumatoid arthritis. He discusses early clinical investigation and the ambition of restoring immune balance; these approaches are presented as developing treatments rather than established cures.